Covered recipient · General Payments record
AMBER H DRISKELL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,380.98
- Reported across 340 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $503.28 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $204.07 | 11 |
| PFIZER INC. | $115.53 | 6 |
| Astellas Pharma US Inc | $39.34 | 2 |
| Dynavax Technologies Corporation | $23.81 | 1 |
| UCB, Inc. | $21.87 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.77 | 1 |
| DEXCOM, INC. | $17.29 | 1 |
| Insulet Corporation | $17.11 | 1 |
| Esperion Therapeutics, Inc. | $16.27 | 1 |
| Lilly USA, LLC | $14.84 | 1 |
| Acerta Pharma LLC | $14.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $16.22 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139276638 | CMS |
| Astellas Pharma US Inc | $23.12 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139374831 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.38 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104782054 | CMS |
| Dexcom, Inc. | $17.29 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153278363 | CMS |
| Dynavax Technologies Corporation | $23.81 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082150531 | CMS |
| Esperion Therapeutics, Inc. | $16.27 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129433612 | CMS |
| Insulet Corporation | $17.11 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116793059 | CMS |
| Lilly USA, LLC | $14.84 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135997527 | CMS |
| Novo Nordisk Inc | $16.01 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097366394 | CMS |
| Novo Nordisk Inc | $14.02 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097277926 | CMS |
| Novo Nordisk Inc | $12.61 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097059350 | CMS |
| Novo Nordisk Inc | $23.05 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097146668 | CMS |
| Novo Nordisk Inc | $18.70 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096609596 | CMS |
| Novo Nordisk Inc | $18.77 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097269489 | CMS |
| Novo Nordisk Inc | $18.58 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097544506 | CMS |
| Novo Nordisk Inc | $18.70 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097473408 | CMS |
| Novo Nordisk Inc | $18.78 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096608402 | CMS |
| Novo Nordisk Inc | $20.90 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096782563 | CMS |
| Novo Nordisk Inc | $23.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097414774 | CMS |
| PFIZER INC. | $16.06 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131144697 | CMS |
| PFIZER INC. | $16.02 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131230035 | CMS |
| PFIZER INC. | $25.00 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132004600 | CMS |
| PFIZER INC. | $17.96 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131685745 | CMS |
| PFIZER INC. | $19.61 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131766496 | CMS |
| PFIZER INC. | $20.88 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132013378 | CMS |
| UCB, Inc. | $21.87 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143277900 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.77 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144586076 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.